Ottawa Hospital Research Institute
L'Institut de recherche de l'Hôpital d'Ottawa
Ottawa, Ontario
Accepting patients
Etentamig
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Bispecific Antibody
- BCMA
- Phase 1
- Has results